Q3 2023 Sanofi SA Earnings Call Transcript
Good morning, good afternoon, and good evening to everyone. Thank you for joining us to review Sanofi's third quarter 2023 results, followed by a Q&A session. As usual, you can find the slides to this call on the Investors page of our website at sanofi.com.
Moving to Slide 3, I would like to remind you that information presented in this call contains forward-looking statements that involves known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our (foreign language) for a description of these risk factors.
With this, please advance to Slide 4. Our speakers on the call today are Paul Hudson, Chief Executive Officer; Jean-Baptiste de Chatillon, Chief Financial Officer; Houman Ashrafian, Global Head of R&D; and Julie Van Ongevalle, Global Business Unit Head, Consumer Healthcare. The Global Business Unit heads, Brian Foard, Thomas Triomphe and Olivier Charmeil, will join for Q&A, to which you have two
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |